NASDAQ:CERC - Cerecor Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$5.0850 +0.58 (+12.87 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$5.0850
Today's Range$4.75 - $5.40
52-Week Range$2.71 - $5.90
Volume816,126 shs
Average Volume73,517 shs
Market Capitalization$207.47 million
P/E Ratio12.11
Dividend YieldN/A
Beta2.16
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and two preclinical stage development candidates, CERC-406 and CERC-425 potential for the treatment of motoric and non-motoric symptoms of Parkinson's disease, as well as other psychiatric and neurological conditions. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.

Receive CERC News and Ratings via Email

Sign-up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CERC
CUSIPN/A
Phone410-522-8707

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.81 million
Cash Flow$0.5319 per share
Book Value$1.07 per share

Profitability

Net Income$11.86 million
Net Margins-241.29%

Miscellaneous

Employees38
Market Cap$207.47 million
OptionableOptionable

Cerecor (NASDAQ:CERC) Frequently Asked Questions

What is Cerecor's stock symbol?

Cerecor trades on the NASDAQ under the ticker symbol "CERC."

How were Cerecor's earnings last quarter?

Cerecor Inc (NASDAQ:CERC) issued its quarterly earnings results on Monday, August, 14th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.15. The firm had revenue of $0.16 million for the quarter. Cerecor had a negative net margin of 241.29% and a negative return on equity of 75.94%. View Cerecor's Earnings History.

When is Cerecor's next earnings date?

Cerecor is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Cerecor.

What price target have analysts set for CERC?

1 brokers have issued 1-year target prices for Cerecor's stock. Their predictions range from $9.00 to $9.00. On average, they expect Cerecor's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 77.0% from the stock's current price. View Analyst Price Targets for Cerecor.

What is the consensus analysts' recommendation for Cerecor?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerecor in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerecor.

Has Cerecor been receiving favorable news coverage?

Media stories about CERC stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cerecor earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next few days.

Who are some of Cerecor's key competitors?

Who are Cerecor's key executives?

Cerecor's management team includes the folowing people:
  • Mr. Peter S. Greenleaf, CEO & Director (Age 49)
  • Ms. Mariam E. Morris, Consultant (Age 51)
  • Dr. Solomon H. Snyder, Founder and Chairman of Scientific Advisory Board (Age 80)
  • Dr. Barbara S. Slusher, Founder and Member of Scientific Advisory Board (Age 54)
  • Mr. Joseph M. Miller CPA, Chief Financial Officer

Who are Cerecor's major shareholders?

Cerecor's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Opaleye Management Inc. (5.36%), Prosight Management LP (0.75%), Geode Capital Management LLC (0.23%), O Shaughnessy Asset Management LLC (0.09%), BlackRock Inc. (0.08%) and Northern Trust Corp (0.05%). Company insiders that own Cerecor stock include Armistice Capital Master Fund, Armistice Capital, Llc, James Archie Harrell Jr, Matthew V Phillips, Peter Greenleaf and Robert Jr Moscato. View Institutional Ownership Trends for Cerecor.

Which major investors are selling Cerecor stock?

CERC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, O Shaughnessy Asset Management LLC and Cambridge Investment Research Advisors Inc.. View Insider Buying and Selling for Cerecor.

Which major investors are buying Cerecor stock?

CERC stock was acquired by a variety of institutional investors in the last quarter, including Opaleye Management Inc., Prosight Management LP, Geode Capital Management LLC, Northern Trust Corp and BlackRock Inc.. Company insiders that have bought Cerecor stock in the last two years include Armistice Capital Master Fund, Armistice Capital, Llc, James Archie Harrell Jr, Matthew V Phillips, Peter Greenleaf and Robert Jr Moscato. View Insider Buying and Selling for Cerecor.

How do I buy shares of Cerecor?

Shares of CERC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerecor's stock price today?

One share of CERC stock can currently be purchased for approximately $5.0850.

How big of a company is Cerecor?

Cerecor has a market capitalization of $207.47 million and generates $27.81 million in revenue each year. The company earns $11.86 million in net income (profit) each year or $0.42 on an earnings per share basis. Cerecor employs 38 workers across the globe.

What is Cerecor's official website?

The official website for Cerecor is http://www.cerecor.com.

How can I contact Cerecor?

Cerecor's mailing address is 400 E. Pratt Street Suite 606, Baltimore MD, 21202. The company can be reached via phone at 410-522-8707 or via email at [email protected]


MarketBeat Community Rating for Cerecor (NASDAQ CERC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  116 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Cerecor and other stocks. Vote "Outperform" if you believe CERC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel